199 related articles for article (PubMed ID: 1989653)
1. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.
Borg A; Sigurdsson H; Clark GM; Fernö M; Fuqua SA; Olsson H; Killander D; McGurie WL
Br J Cancer; 1991 Jan; 63(1):136-42. PubMed ID: 1989653
[TBL] [Abstract][Full Text] [Related]
2. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer.
Fantl V; Richards MA; Smith R; Lammie GA; Johnstone G; Allen D; Gregory W; Peters G; Dickson C; Barnes DM
Eur J Cancer; 1990 Apr; 26(4):423-9. PubMed ID: 2141507
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
4. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
5. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
[TBL] [Abstract][Full Text] [Related]
6. Amplification of fgfr4 gene in human breast and gynecological cancers.
Jaakkola S; Salmikangas P; Nylund S; Partanen J; Armstrong E; Pyrhönen S; Lehtovirta P; Nevanlinna H
Int J Cancer; 1993 May; 54(3):378-82. PubMed ID: 8099571
[TBL] [Abstract][Full Text] [Related]
7. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.
Lese CM; Rossie KM; Appel BN; Reddy JK; Johnson JT; Myers EN; Gollin SM
Genes Chromosomes Cancer; 1995 Apr; 12(4):288-95. PubMed ID: 7539284
[TBL] [Abstract][Full Text] [Related]
8. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
[TBL] [Abstract][Full Text] [Related]
9. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
10. c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.
Berns EM; Klijn JG; van Putten WL; van Staveren IL; Portengen H; Foekens JA
Cancer Res; 1992 Mar; 52(5):1107-13. PubMed ID: 1737370
[TBL] [Abstract][Full Text] [Related]
11. HST1 and INT2 gene coamplification in a squamous cell carcinoma of the gallbladder.
Tsuda T; Nakatani H; Tahara E; Sakamoto H; Terada M; Sugimura T
Jpn J Clin Oncol; 1989 Mar; 19(1):26-9. PubMed ID: 2921814
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
Borg A; Tandon AK; Sigurdsson H; Clark GM; Fernö M; Fuqua SA; Killander D; McGuire WL
Cancer Res; 1990 Jul; 50(14):4332-7. PubMed ID: 1973070
[TBL] [Abstract][Full Text] [Related]
13. Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.
Olsson H; Borg A; Fernö M; Ranstam J; Sigurdsson H
J Natl Cancer Inst; 1991 Oct; 83(20):1483-7. PubMed ID: 1920494
[TBL] [Abstract][Full Text] [Related]
14. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer.
Yoshida MC; Wada M; Satoh H; Yoshida T; Sakamoto H; Miyagawa K; Yokota J; Koda T; Kakinuma M; Sugimura T
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4861-4. PubMed ID: 3290903
[TBL] [Abstract][Full Text] [Related]
15. INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes.
Pauley RJ; Gimotty PA; Paine TJ; Dawson PJ; Wolman SR
Breast Cancer Res Treat; 1996; 37(1):65-76. PubMed ID: 8750529
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
Tiwari RK; Borgen PI; Wong GY; Cordon-Cardo C; Osborne MP
Anticancer Res; 1992; 12(2):419-25. PubMed ID: 1349794
[TBL] [Abstract][Full Text] [Related]
17. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.
Schuuring E; Verhoeven E; van Tinteren H; Peterse JL; Nunnink B; Thunnissen FB; Devilee P; Cornelisse CJ; van de Vijver MJ; Mooi WJ
Cancer Res; 1992 Oct; 52(19):5229-34. PubMed ID: 1394126
[TBL] [Abstract][Full Text] [Related]
18. int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc.
Henry JA; Hennessy C; Levett DL; Lennard TW; Westley BR; May FE
Int J Cancer; 1993 Mar; 53(5):774-80. PubMed ID: 8449602
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.
Seshadri R; Firgaira FA; Horsfall DJ; McCaul K; Setlur V; Kitchen P
J Clin Oncol; 1993 Oct; 11(10):1936-42. PubMed ID: 8105035
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
Machotka SV; Garrett CT; Schwartz AM; Callahan R
Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
